These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1149361)

  • 1. Prediction of drug dosage in patients with renal failure using data derived from normal subjects.
    Welling PG; Craig WA; Kunin CM
    Clin Pharmacol Ther; 1975 Jul; 18(1):45-52. PubMed ID: 1149361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics in renal failure.
    Nancarrow C; Mather LE
    Anaesth Intensive Care; 1983 Nov; 11(4):350-60. PubMed ID: 6359952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics in patients with renal failure.
    Maher JF
    Clin Nephrol; 1984 Jan; 21(1):39-46. PubMed ID: 6368069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of cefazolin in patients with renal failure; special reference to hemodialysis.
    Brogard JM; Pinget M; Brandt C; Lavillaureix J
    J Clin Pharmacol; 1977 Apr; 17(4):225-30. PubMed ID: 849996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The elimination of tritiated doxycycline in normal subjects and in patients with severely impaired renal function.
    Mahon WA; Johnson GE; Endrenyl L; Kelly MF; Fenton SS
    Scand J Infect Dis Suppl; 1976; (9):24-31. PubMed ID: 1070145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal disease and drug metabolism: an overview.
    Gibson TP
    Am J Kidney Dis; 1986 Jul; 8(1):7-17. PubMed ID: 3524205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic predictions for patients with renal impairment: focus on peptides and protein drugs.
    Czock D; Keller F; Seidling HM
    Br J Clin Pharmacol; 2012 Jul; 74(1):66-74. PubMed ID: 22242561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nomogram for drug dosage adjustment in patients with renal failure.
    Bjornsson TD
    Clin Pharmacokinet; 1986; 11(2):164-70. PubMed ID: 3956049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug dosage in renal disease.
    Dettli L
    Clin Pharmacokinet; 1976; 1(2):126-34. PubMed ID: 797495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of chronic renal failure on the disposition of highly hepatically metabolized drugs.
    Yuan R; Venitz J
    Int J Clin Pharmacol Ther; 2000 May; 38(5):245-53. PubMed ID: 10839468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in erythromycin pharmacokinetics induced by renal failure.
    Kanfer A; Stamatakis G; Torlotin JC; Fredj G; Kenouch S; Méry JP
    Clin Nephrol; 1987 Mar; 27(3):147-50. PubMed ID: 3494560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Characteristics of the pharmacokinetics of drugs in renal failure].
    Nadzhimutdinov KN; Krakovskiĭ ME
    Farmakol Toksikol; 1985; 48(5):109-13. PubMed ID: 3908139
    [No Abstract]   [Full Text] [Related]  

  • 13. Criticism of pharmacokinetic clearance concepts.
    Keller F; Schoole J
    Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):563-8. PubMed ID: 6654532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacokinetics of cefotaxime in patients with chronic renal impairment (author's transl)].
    Fillastre JP; Ings RM; Leroy A; Humbert G; Godin M
    Nouv Presse Med; 1981 Feb; 10(8):574-9. PubMed ID: 6259595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-dose kinetics and dosage of mecillinam in renal failure and haemodialysis.
    Schapira A
    Clin Pharmacokinet; 1984; 9(4):364-70. PubMed ID: 6088153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of chronic renal insufficiency on the pharmacokinetics of doxycycline in man.
    Houin G; Brunner F; Nebout T; Cherfaoui M; Lagrue G; Tillement JP
    Br J Clin Pharmacol; 1983 Sep; 16(3):245-52. PubMed ID: 6626415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary studies on the elimination of 3-H doxycycline in normal subjects and in patients with severely impaired renal function.
    Mahon WA; Johnson GE; Kelly MF; Fenton SS
    Rev Can Biol; 1973; 32():Suppl:107-11. PubMed ID: 4777591
    [No Abstract]   [Full Text] [Related]  

  • 18. The biotransformation of drugs in renal failure.
    Reidenberg MM
    Am J Med; 1977 Apr; 62(4):482-5. PubMed ID: 851117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hepatic clearance of drugs in kidney failure].
    Balant L
    Nephrologie; 1983; 4(2):45-7. PubMed ID: 6136004
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacokinetics of cefaclor in normal subjects and patients with chronic renal failure.
    Bloch R; Szwed JJ; Sloan RS; Luft FC
    Antimicrob Agents Chemother; 1977 Dec; 12(6):730-2. PubMed ID: 931372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.